Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction

Amanda Roman, Neeraj Desai, David Krantz, Hsiao Pin Liu, Jonathan Rosner, Nidhi Vohra, Burton Rochelson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

OBJECTIVES: Our primary objective was to determine the association of maternal serum analytes in pregnancies complicated by intrauterine growth restriction (IUGR) stratified by umbilical artery (UA) Doppler versus pregnancies with appropriately grown for gestational age (AGA) and its potential use as screening model.

METHODS: Retrospective cohort evaluating first and second trimester maternal serum aneuploidy screening markers in women complicated with IUGR [90 with absent or reversed end diastolic velocity (AREDV), 46 with UA systolic/diastolic ratio ≥95th percentile and 215 with normal UA Doppler] versus 2590 women with AGA fetuses (control).

RESULTS: Extreme levels of each analyte were significantly more common in the IUGR/AREDV group than in AGA group: inhibin A >97th percentile [≥2.27 multiples of the median (MoM)], OR: 41 (95% CI: 21-80); unconjugated estriol <3rd percentile (≤0.6 MoM), OR: 17.2 (95% CI: 8.1-42); AFP >97th percentile (≥1.88 MoM), OR: 15 (95% CI: 8.2-27); PAPP-A <3rd percentile (≤0.33 MoM), OR: 13 (95% CI: 6.6-25.5); and free-beta human chorionic gonadotrophin second trimester >97th percentile (≥3.24 MoM), OR: 11.6 (95% CI: 4.2-32). In a subgroup of pregnancies in which all markers were evaluated on each patient, a combination of abnormal markers detected 73% (95% CI: 54-87%) of IUGR/AREDV fetuses. When maternal risk factors were included into the risk calculation, it increased to 91% (95% CI: 76-98%).

CONCLUSIONS: Abnormal maternal serum aneuploidy markers preferentially identify those pregnancies at greatest risk of IUGR with AREDV in the UA.

Original languageEnglish (US)
Pages (from-to)692-698
Number of pages7
JournalPrenatal Diagnosis
Volume34
Issue number7
DOIs
StatePublished - Jul 1 2014
Externally publishedYes

Fingerprint

Umbilical Arteries
Blood Vessels
Mothers
Gestational Age
Growth
Pregnancy
Serum
Aneuploidy
Fetus
Pregnancy-Associated Plasma Protein-A
Estriol
Second Pregnancy Trimester
First Pregnancy Trimester
Age Groups
Biomarkers

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Genetics(clinical)

Cite this

Roman, A., Desai, N., Krantz, D., Liu, H. P., Rosner, J., Vohra, N., & Rochelson, B. (2014). Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction. Prenatal Diagnosis, 34(7), 692-698. https://doi.org/10.1002/pd.4369

Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction. / Roman, Amanda; Desai, Neeraj; Krantz, David; Liu, Hsiao Pin; Rosner, Jonathan; Vohra, Nidhi; Rochelson, Burton.

In: Prenatal Diagnosis, Vol. 34, No. 7, 01.07.2014, p. 692-698.

Research output: Contribution to journalArticle

Roman, A, Desai, N, Krantz, D, Liu, HP, Rosner, J, Vohra, N & Rochelson, B 2014, 'Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction', Prenatal Diagnosis, vol. 34, no. 7, pp. 692-698. https://doi.org/10.1002/pd.4369
Roman, Amanda ; Desai, Neeraj ; Krantz, David ; Liu, Hsiao Pin ; Rosner, Jonathan ; Vohra, Nidhi ; Rochelson, Burton. / Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction. In: Prenatal Diagnosis. 2014 ; Vol. 34, No. 7. pp. 692-698.
@article{d12eca7cf68245cf9e88e36879859145,
title = "Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction",
abstract = "OBJECTIVES: Our primary objective was to determine the association of maternal serum analytes in pregnancies complicated by intrauterine growth restriction (IUGR) stratified by umbilical artery (UA) Doppler versus pregnancies with appropriately grown for gestational age (AGA) and its potential use as screening model.METHODS: Retrospective cohort evaluating first and second trimester maternal serum aneuploidy screening markers in women complicated with IUGR [90 with absent or reversed end diastolic velocity (AREDV), 46 with UA systolic/diastolic ratio ≥95th percentile and 215 with normal UA Doppler] versus 2590 women with AGA fetuses (control).RESULTS: Extreme levels of each analyte were significantly more common in the IUGR/AREDV group than in AGA group: inhibin A >97th percentile [≥2.27 multiples of the median (MoM)], OR: 41 (95{\%} CI: 21-80); unconjugated estriol <3rd percentile (≤0.6 MoM), OR: 17.2 (95{\%} CI: 8.1-42); AFP >97th percentile (≥1.88 MoM), OR: 15 (95{\%} CI: 8.2-27); PAPP-A <3rd percentile (≤0.33 MoM), OR: 13 (95{\%} CI: 6.6-25.5); and free-beta human chorionic gonadotrophin second trimester >97th percentile (≥3.24 MoM), OR: 11.6 (95{\%} CI: 4.2-32). In a subgroup of pregnancies in which all markers were evaluated on each patient, a combination of abnormal markers detected 73{\%} (95{\%} CI: 54-87{\%}) of IUGR/AREDV fetuses. When maternal risk factors were included into the risk calculation, it increased to 91{\%} (95{\%} CI: 76-98{\%}).CONCLUSIONS: Abnormal maternal serum aneuploidy markers preferentially identify those pregnancies at greatest risk of IUGR with AREDV in the UA.",
author = "Amanda Roman and Neeraj Desai and David Krantz and Liu, {Hsiao Pin} and Jonathan Rosner and Nidhi Vohra and Burton Rochelson",
year = "2014",
month = "7",
day = "1",
doi = "10.1002/pd.4369",
language = "English (US)",
volume = "34",
pages = "692--698",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction

AU - Roman, Amanda

AU - Desai, Neeraj

AU - Krantz, David

AU - Liu, Hsiao Pin

AU - Rosner, Jonathan

AU - Vohra, Nidhi

AU - Rochelson, Burton

PY - 2014/7/1

Y1 - 2014/7/1

N2 - OBJECTIVES: Our primary objective was to determine the association of maternal serum analytes in pregnancies complicated by intrauterine growth restriction (IUGR) stratified by umbilical artery (UA) Doppler versus pregnancies with appropriately grown for gestational age (AGA) and its potential use as screening model.METHODS: Retrospective cohort evaluating first and second trimester maternal serum aneuploidy screening markers in women complicated with IUGR [90 with absent or reversed end diastolic velocity (AREDV), 46 with UA systolic/diastolic ratio ≥95th percentile and 215 with normal UA Doppler] versus 2590 women with AGA fetuses (control).RESULTS: Extreme levels of each analyte were significantly more common in the IUGR/AREDV group than in AGA group: inhibin A >97th percentile [≥2.27 multiples of the median (MoM)], OR: 41 (95% CI: 21-80); unconjugated estriol <3rd percentile (≤0.6 MoM), OR: 17.2 (95% CI: 8.1-42); AFP >97th percentile (≥1.88 MoM), OR: 15 (95% CI: 8.2-27); PAPP-A <3rd percentile (≤0.33 MoM), OR: 13 (95% CI: 6.6-25.5); and free-beta human chorionic gonadotrophin second trimester >97th percentile (≥3.24 MoM), OR: 11.6 (95% CI: 4.2-32). In a subgroup of pregnancies in which all markers were evaluated on each patient, a combination of abnormal markers detected 73% (95% CI: 54-87%) of IUGR/AREDV fetuses. When maternal risk factors were included into the risk calculation, it increased to 91% (95% CI: 76-98%).CONCLUSIONS: Abnormal maternal serum aneuploidy markers preferentially identify those pregnancies at greatest risk of IUGR with AREDV in the UA.

AB - OBJECTIVES: Our primary objective was to determine the association of maternal serum analytes in pregnancies complicated by intrauterine growth restriction (IUGR) stratified by umbilical artery (UA) Doppler versus pregnancies with appropriately grown for gestational age (AGA) and its potential use as screening model.METHODS: Retrospective cohort evaluating first and second trimester maternal serum aneuploidy screening markers in women complicated with IUGR [90 with absent or reversed end diastolic velocity (AREDV), 46 with UA systolic/diastolic ratio ≥95th percentile and 215 with normal UA Doppler] versus 2590 women with AGA fetuses (control).RESULTS: Extreme levels of each analyte were significantly more common in the IUGR/AREDV group than in AGA group: inhibin A >97th percentile [≥2.27 multiples of the median (MoM)], OR: 41 (95% CI: 21-80); unconjugated estriol <3rd percentile (≤0.6 MoM), OR: 17.2 (95% CI: 8.1-42); AFP >97th percentile (≥1.88 MoM), OR: 15 (95% CI: 8.2-27); PAPP-A <3rd percentile (≤0.33 MoM), OR: 13 (95% CI: 6.6-25.5); and free-beta human chorionic gonadotrophin second trimester >97th percentile (≥3.24 MoM), OR: 11.6 (95% CI: 4.2-32). In a subgroup of pregnancies in which all markers were evaluated on each patient, a combination of abnormal markers detected 73% (95% CI: 54-87%) of IUGR/AREDV fetuses. When maternal risk factors were included into the risk calculation, it increased to 91% (95% CI: 76-98%).CONCLUSIONS: Abnormal maternal serum aneuploidy markers preferentially identify those pregnancies at greatest risk of IUGR with AREDV in the UA.

UR - http://www.scopus.com/inward/record.url?scp=85027946992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027946992&partnerID=8YFLogxK

U2 - 10.1002/pd.4369

DO - 10.1002/pd.4369

M3 - Article

C2 - 24677013

AN - SCOPUS:85027946992

VL - 34

SP - 692

EP - 698

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 7

ER -